Rachel M. Locklin - Concepedia

Concepedia

Author

Rachel M. Locklin

Nuffield Orthopaedic Centre

Also Known As

R Locklin, R M Locklin, R. Locklin, R. M. Locklin, R.M. Locklin, RACHEL M. LOCKLIN, Rachel Locklin, Rachel M Locklin, Rachel M. Locklin

32

Publications

1.1K

Citations

14

H-Index

31

Concepts

All Affiliations

Nuffield Orthopaedic Centre University of Oxford Mayo Clinic

RM

About

Rachel M. Locklin is an author at Nuffield Orthopaedic Centre specializing in medicine, cell biology, and regenerative medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	293
2	Cell Biology	6	6	270
3	Health Sciences	3	3	203
4	Engineering	1	1	30
5	Biomedical Engineering	1	1	30

Rachel M. Locklin

×

15

Publications

1.1K

Citations

14

H-Index

	Year	Citations
Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone Rachel M. Locklin, Sundeep Khosla, Russell T. Turner, Journal of Cellular Biochemistry	2003	216
A gain-of-function mutation of <i>Fgfr2c</i> demonstrates the roles of this receptor variant in osteogenesis Veraragavan P. Eswarakumar, Mark C. Horowitz, Rachel M. Locklin, Proceedings of the National Academy of Sciences	2004	215
Differences between bisphosphonates in binding affinities for hydroxyapatite Michelle A. Lawson, Zhidao Xia, B.L. Barnett, Journal of Biomedical Materials Research Part B Applied Biomaterials	2009	116
Effects of TGFβ and BFGF on the differentiation of human bone marrow stromal fibroblasts Rachel M. Locklin, Richard O. C. Oreffo, James T. Triffitt Cell Biology International OsteoporosisRegenerative MedicineMetabolic SyndromeBone Morphogenic ProteinHematology	1999	95
LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis Sanyuan Sun, Rachel M. Locklin, C M Shipman, Arthritis & Rheumatism	2006	94
Assessment of Gene Regulation by Bone Morphogenetic Protein 2 in Human Marrow Stromal Cells Using Gene Array Technology Rachel M. Locklin, B. Lawrence Riggs, K. C. Hicok, Journal of Bone and Mineral Research	2001	89
In vitro effects of growth factors and dexamethasone on rat marrow stromal cells. Rachel M. Locklin, M.C. Williamson, J.N. Beresford, PubMed Tgf BetaOsteoporosisOrthopaedic SurgeryRegenerative MedicineBone Morphogenic Protein	1995	74
MODULATION OF OSTEOGENIC DIFFERENTIATION IN HUMAN SKELETAL CELLS <i>IN VITRO</i> BY 5‐AZACYTIDINE Rachel M. Locklin, Richard O. C. Oreffo, James T. Triffitt Cell Biology International Developmental BiologyBone Morphogenic ProteinOsteoarthritisMg63 Osteosarcoma CellsSkeletal Biology	1998	34
Enhanced osteoblastogenesis in three-dimensional collagen gels Brya G. Matthews, Dorit Naot, Karen E. Callon, BoneKEy Reports	2014	32
Efficient characterisation of human cell–bioceramic interactions in vitro and in vivo by using enhanced GFP-labelled mesenchymal stem cells Zhidao Xia, Hua Ye, Rachel M. Locklin, Biomaterials Tissue EngineeringRegenerative MedicineEngineeringHuman Cell–bioceramic InteractionsMedicine	2005	30

Page 1